Quantbot Technologies
TBIO icon

Quantbot Technologies’s Translate Bio, Inc. Common Stock TBIO Stock Holding History

Quantbot Technologies’s Portfolio TBIO Stock Details TBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-700
Closed -$11K – 2040
2021
Q1 		$11K Buy
+700
New +$15.9K ﹤0.01% 1241
2020
Q4 		– Sell
-600
Closed -$8K – 1828
2020
Q3 		$8K Buy
+600
New +$9.25K ﹤0.01% 1143

Other funds holding TBIO

Baupost Group
Baupost Group Boston, Massachusetts $5.42B AUM 22.93% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Frazier Management
Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Atlas Venture Advisors
Atlas Venture Advisors Boston, Massachusetts $111M AUM 45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Quantbot Technologies's TBIO Position: Q2 2021 in Review

Quantbot Technologies sold out of Translate Bio, Inc. Common Stock (TBIO) in Q2 2021, closing a stake of 700 shares — an estimated $11K sold.

Quantbot Technologies first reported a position in TBIO in Q3 2020 and held it in 2 quarters. The position peaked at $11K in Q1 2021. 145 funds tracked by Wall St. Rank hold TBIO as of Q2 2021.

  • Quantbot Technologies reported no remaining Translate Bio, Inc. Common Stock position as of Q2 2021 after selling out during the quarter.
  • Quantbot Technologies sold 700 Translate Bio, Inc. Common Stock shares in Q2 2021, an estimated $11K.
  • Quantbot Technologies first reported a position in Translate Bio, Inc. Common Stock in Q3 2020 and held it in 2 quarters.
  • Quantbot Technologies's Translate Bio, Inc. Common Stock position peaked at $11K in Q1 2021.
  • 145 funds tracked by Wall St. Rank held Translate Bio, Inc. Common Stock as of Q2 2021.

Based on Quantbot Technologies's 13F filing for Q2 2021, filed 12 Aug 2021.